Maintenance Dose of Propofol
For maintenance sedation, propofol should be administered at 50-100 mcg/kg/min (3-6 mg/kg/h) for general anesthesia, 25-75 mcg/kg/min for moderate sedation (MAC), and 5-50 mcg/kg/min (0.3-3 mg/kg/h) for ICU sedation, with the specific rate determined by clinical context and patient factors. 1
General Anesthesia Maintenance
Standard maintenance infusion rates:
- Initial maintenance: 150-200 mcg/kg/min for the first 10-15 minutes following induction 1
- Subsequent maintenance: Decrease by 30-50% after the initial period, targeting 50-100 mcg/kg/min to optimize recovery 1
- When propofol is the primary agent: Maintenance rates should not be less than 100 mcg/kg/min, supplemented with continuous opioid administration 1
- When opioid is the primary agent: Propofol maintenance rates should not be less than 50 mcg/kg/min 1
Pediatric patients (≥2 months):
- Initial maintenance: 200-300 mcg/kg/min immediately following induction 1
- After first 30 minutes: 125-150 mcg/kg/min typically needed 1
- Younger children require higher maintenance rates than older children 1
Monitored Anesthesia Care (MAC) Sedation
For moderate sedation during procedures:
- Typical range: 25-75 mcg/kg/min (1.5-4.5 mg/kg/h) 1
- Initiation: 100-150 mcg/kg/min for 3-5 minutes, then titrate down 1
- Variable rate infusion is preferable over intermittent boluses 1
Endoscopic sedation (nurse-administered):
- Mean doses: 107-245 mg total for EGD, 144-287 mg total for colonoscopy 2
- Alternative lower-dose approach: Mean 72 mg for EGD, 94 mg for colonoscopy when targeting moderate rather than deep sedation 2
ICU Sedation
For mechanically ventilated patients:
- Initiation: Start at 5 mcg/kg/min (0.3 mg/kg/h) 1
- Titration: Increase by 5-10 mcg/kg/min increments every 5 minutes minimum until desired sedation achieved 1
- Maintenance range: 5-50 mcg/kg/min (0.3-3 mg/kg/h) for most patients 1
- Maximum safe dose: Do not exceed 4 mg/kg/h (67 mcg/kg/min) unless benefits outweigh risks 1
Critical warning: Doses >70 mcg/kg/min for >48 hours increase risk of Propofol Infusion Syndrome (PRIS), characterized by metabolic acidosis, rhabdomyolysis, arrhythmias, and up to 33% mortality 3, 4
Palliative Sedation
For refractory symptoms at end of life:
Special Population Adjustments
Elderly, debilitated, or ASA-PS III/IV patients:
- Avoid rapid boluses entirely 1
- Reduce maintenance rates by approximately 30-50% from standard dosing 1
- These patients have exaggerated hemodynamic and respiratory responses 1
CYP2B6 poor metabolizers:
- Reduce maintenance infusion to 25 mcg/kg/min (approximately 50% reduction from standard 50-100 mcg/kg/min range) 3
Patients receiving concurrent opioids:
- Propofol requirements decrease with adequate opioid analgesia 1
- Morphine premedication reduces necessary maintenance rates compared to non-narcotic premedication 1
Critical Safety Considerations
Cardiovascular monitoring:
- Propofol causes dose-dependent decreases in cardiac output, systemic vascular resistance, and arterial pressure 2, 3
- Continuous monitoring of heart rate, blood pressure, and oxygen saturation is mandatory 6
- Hypotension occurs in 5-7% of patients 6
Respiratory effects:
- Propofol causes dose-dependent respiratory depression 3
- Transient apnea episodes can occur, lasting 1-37 seconds 2
- Oxygen desaturation (SpO2 <90%) occurs in approximately 16% of cases 7
Propofol has no analgesic properties:
- Must be combined with opioids or other analgesics for painful procedures 3, 1
- Do not use as sole agent without adequate analgesia 6
Lipid content: